Standard
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. / Abelsson, J; Merup, M; Birgegård, G; Bjerrum, Ole Weis; Brinch, L; Brune, M; Johansson, Per; Kauppila, M; Lenhoff, S; Liljeholm, M; Malm, C; Remes, K; Vindelöv, L; Andréasson, B.
I:
Bone Marrow Transplantation, Bind 47, 2012, s. 380-386.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Abelsson, J, Merup, M, Birgegård, G, Bjerrum, OW, Brinch, L, Brune, M, Johansson, P, Kauppila, M, Lenhoff, S, Liljeholm, M, Malm, C, Remes, K, Vindelöv, L & Andréasson, B 2012, '
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries',
Bone Marrow Transplantation, bind 47, s. 380-386.
https://doi.org/10.1038/bmt.2011.91APA
Abelsson, J., Merup, M., Birgegård, G., Bjerrum, O. W., Brinch, L., Brune, M., Johansson, P., Kauppila, M., Lenhoff, S., Liljeholm, M., Malm, C., Remes, K., Vindelöv, L., & Andréasson, B. (2012).
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.
Bone Marrow Transplantation,
47, 380-386.
https://doi.org/10.1038/bmt.2011.91Vancouver
Abelsson J, Merup M, Birgegård G, Bjerrum OW, Brinch L, Brune M o.a.
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.
Bone Marrow Transplantation. 2012;47:380-386.
https://doi.org/10.1038/bmt.2011.91Author
Abelsson, J ; Merup, M ; Birgegård, G ; Bjerrum, Ole Weis ; Brinch, L ; Brune, M ; Johansson, Per ; Kauppila, M ; Lenhoff, S ; Liljeholm, M ; Malm, C ; Remes, K ; Vindelöv, L ; Andréasson, B. / The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. I: Bone Marrow Transplantation. 2012 ; Bind 47. s. 380-386.
Bibtex
@article{7697e748de3c485892b05161fb0052ff,
title = "The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries",
abstract = "Between 1982 and 2009 a total of 92 patients with myelofibrosis (MF) in chronic phase underwent allo-SCT in nine Nordic transplant centers. Myeloablative conditioning (MAC) was given to 40 patients, and reduced intensity conditioning (RIC) was used in 52 patients. The mean age in the two groups at transplantation was 46±12 and 55±8 years, respectively (P",
author = "J Abelsson and M Merup and G Birgeg{\aa}rd and Bjerrum, {Ole Weis} and L Brinch and M Brune and Per Johansson and M Kauppila and S Lenhoff and M Liljeholm and C Malm and K Remes and L Vindel{\"o}v and B Andr{\'e}asson",
year = "2012",
doi = "10.1038/bmt.2011.91",
language = "English",
volume = "47",
pages = "380--386",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "nature publishing group",
}
RIS
TY - JOUR
T1 - The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
AU - Abelsson, J
AU - Merup, M
AU - Birgegård, G
AU - Bjerrum, Ole Weis
AU - Brinch, L
AU - Brune, M
AU - Johansson, Per
AU - Kauppila, M
AU - Lenhoff, S
AU - Liljeholm, M
AU - Malm, C
AU - Remes, K
AU - Vindelöv, L
AU - Andréasson, B
PY - 2012
Y1 - 2012
N2 - Between 1982 and 2009 a total of 92 patients with myelofibrosis (MF) in chronic phase underwent allo-SCT in nine Nordic transplant centers. Myeloablative conditioning (MAC) was given to 40 patients, and reduced intensity conditioning (RIC) was used in 52 patients. The mean age in the two groups at transplantation was 46±12 and 55±8 years, respectively (P
AB - Between 1982 and 2009 a total of 92 patients with myelofibrosis (MF) in chronic phase underwent allo-SCT in nine Nordic transplant centers. Myeloablative conditioning (MAC) was given to 40 patients, and reduced intensity conditioning (RIC) was used in 52 patients. The mean age in the two groups at transplantation was 46±12 and 55±8 years, respectively (P
U2 - 10.1038/bmt.2011.91
DO - 10.1038/bmt.2011.91
M3 - Journal article
C2 - 21552298
VL - 47
SP - 380
EP - 386
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
SN - 0268-3369
ER -
